ATE542553T1 - Dezellularisierte omentummatrix und ihre verwendung - Google Patents
Dezellularisierte omentummatrix und ihre verwendungInfo
- Publication number
- ATE542553T1 ATE542553T1 AT08867075T AT08867075T ATE542553T1 AT E542553 T1 ATE542553 T1 AT E542553T1 AT 08867075 T AT08867075 T AT 08867075T AT 08867075 T AT08867075 T AT 08867075T AT E542553 T1 ATE542553 T1 AT E542553T1
- Authority
- AT
- Austria
- Prior art keywords
- omentum
- decellularized
- decellularized omentum
- matrix
- omentum matrix
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
- A61L27/3645—Connective tissue
- A61L27/365—Bones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3808—Endothelial cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/36—Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/960,010 US20090163990A1 (en) | 2007-12-19 | 2007-12-19 | Decellularized omentum matrix and uses thereof |
PCT/US2008/085450 WO2009085547A2 (en) | 2007-12-19 | 2008-12-04 | Decellularized omentum matrix and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE542553T1 true ATE542553T1 (de) | 2012-02-15 |
Family
ID=40293881
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT08867075T ATE542553T1 (de) | 2007-12-19 | 2008-12-04 | Dezellularisierte omentummatrix und ihre verwendung |
Country Status (9)
Country | Link |
---|---|
US (1) | US20090163990A1 (de) |
EP (1) | EP2229191B1 (de) |
JP (1) | JP5599722B2 (de) |
CN (1) | CN101945676B (de) |
AT (1) | ATE542553T1 (de) |
AU (1) | AU2008343485B2 (de) |
BR (1) | BRPI0821406A2 (de) |
CA (1) | CA2709998A1 (de) |
WO (1) | WO2009085547A2 (de) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008109407A2 (en) | 2007-03-02 | 2008-09-12 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Extracellular matrix-derived gels and related methods |
US20110143429A1 (en) * | 2008-04-30 | 2011-06-16 | Iksoo Chun | Tissue engineered blood vessels |
WO2009134991A2 (en) | 2008-04-30 | 2009-11-05 | Ethicon, Inc. | Tissue engineered blood vessel |
US20110165676A1 (en) * | 2009-11-06 | 2011-07-07 | The Children's Mercy Hospital | Method for decellularization |
US9814744B2 (en) * | 2009-12-22 | 2017-11-14 | University of Pittsburg—Of the Commonwealth System of Higher Education | Decellularized adipose cell growth scaffold |
JP2013165740A (ja) * | 2010-05-14 | 2013-08-29 | Waseda Univ | 無細胞化方法及び人体移植用人工組織 |
US10130736B1 (en) | 2010-05-14 | 2018-11-20 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
US8883210B1 (en) | 2010-05-14 | 2014-11-11 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
US9352003B1 (en) | 2010-05-14 | 2016-05-31 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
WO2011150055A2 (en) | 2010-05-25 | 2011-12-01 | Cook Biotech Incorporated | Methods, substrates, and systems useful for cell seeding of medical grafts |
EP2661243B1 (de) * | 2011-01-06 | 2022-10-12 | Humacyte, Inc. | Gewebegezüchtete konstrukte |
WO2012134433A1 (en) * | 2011-03-25 | 2012-10-04 | Cooperlabs Limited | Heat-extracted omentum extracts, compositions, methods of preparing and uses thereof |
US8834928B1 (en) | 2011-05-16 | 2014-09-16 | Musculoskeletal Transplant Foundation | Tissue-derived tissugenic implants, and methods of fabricating and using same |
CN102266585B (zh) * | 2011-07-20 | 2013-10-30 | 中国人民解放军第三军医大学第一附属医院 | 一种用于女性盆底的生物复合补片及其制造方法 |
CN102580140B (zh) * | 2012-03-09 | 2013-11-06 | 潘银根 | 一种制备脱细胞生物膜敷料的方法 |
US8936651B2 (en) | 2013-03-14 | 2015-01-20 | Ethicon, Inc. | Decellularized omentum matrix and uses thereof |
WO2014149953A1 (en) * | 2013-03-15 | 2014-09-25 | Cryolife, Inc. | Methods for preparing tissue implants |
WO2014188420A1 (en) * | 2013-05-20 | 2014-11-27 | Ramot At Tel-Aviv University Ltd. | Metal-coated scaffolds for tissue engineering |
WO2014207744A1 (en) | 2013-06-24 | 2014-12-31 | Ramot At Tel-Aviv University Ltd. | Omentum based scaffold and delivery system |
WO2015017500A1 (en) | 2013-07-30 | 2015-02-05 | Musculoskeletal Transplant Foundation | Acellular soft tissue-derived matrices and methods for preparing same |
EP2832379B1 (de) * | 2013-07-31 | 2015-07-22 | Biotronik AG | Verfahren zur Aufbereitung von biologischem Gewebe |
WO2015071912A1 (en) | 2013-11-17 | 2015-05-21 | Ramot At Tel-Aviv University Ltd. | Electronic scaffold and uses thereof |
CN103656750B (zh) * | 2013-12-07 | 2014-12-24 | 西南交通大学 | 一种在心血管植入材料表面改善多种仿生功能的方法 |
US9238090B1 (en) | 2014-12-24 | 2016-01-19 | Fettech, Llc | Tissue-based compositions |
CA3177726A1 (en) | 2015-05-21 | 2016-11-24 | Musculoskeletal Transplant Foundation | Modified demineralized cortical bone fibers |
CN104877956A (zh) * | 2015-06-23 | 2015-09-02 | 华东医院 | 一种猪脂肪细胞外基质的提取工艺 |
US11052175B2 (en) | 2015-08-19 | 2021-07-06 | Musculoskeletal Transplant Foundation | Cartilage-derived implants and methods of making and using same |
CN107949345B (zh) * | 2015-09-11 | 2021-02-26 | 生命细胞公司 | 穿孔的组织基质 |
EP4059507A1 (de) | 2015-12-16 | 2022-09-21 | Ramot at Tel-Aviv University Ltd. | Partikel mit dezellulärisiertem omentum |
CN108079363A (zh) * | 2017-12-19 | 2018-05-29 | 广州昕生医学材料有限公司 | 一种用于动物组织脱细胞处理的试剂盒及其应用 |
CN108992709B (zh) * | 2018-07-27 | 2021-05-14 | 山东省眼科研究所 | 一种脱细胞神经基质材料及其制备方法和应用 |
CN111110919A (zh) * | 2019-12-30 | 2020-05-08 | 广东泓志生物科技有限公司 | 大网膜脱细胞基质材料的制备方法及软骨组织的构建方法 |
EP4108265A4 (de) * | 2020-02-17 | 2024-03-13 | Venus Medtech Hangzhou Inc | Funktionalisiertes biologisches matrixmaterial, verfahren zu seiner herstellung und seine verwendung |
CN111643734A (zh) * | 2020-05-25 | 2020-09-11 | 内蒙古自治区中医药研究所 | 一种应用于半月板损伤修复的脱细胞基质 |
KR102311441B1 (ko) * | 2020-05-29 | 2021-10-13 | 주식회사 로킷헬스케어 | 그물막을 이용한 신장 치료용 조성물, 이를 포함하는 신장 치료용 의료 키트, 및 이의 경화물을 포함하는 신장 치료용 필름 |
KR102586304B1 (ko) * | 2020-12-21 | 2023-10-11 | 주식회사 엘앤씨바이오 | 무세포 신경 이식재 및 그 제조방법 |
WO2023095149A1 (en) | 2021-11-29 | 2023-06-01 | Ramot At Tel-Aviv University Ltd. | Methods and compositions for treating spinal cord injury |
CN114246986B (zh) * | 2021-12-29 | 2022-08-23 | 中国人民解放军陆军军医大学 | 一种基于原位调控免疫反应的心血管植入物及其制备方法 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4707369A (en) * | 1984-02-23 | 1987-11-17 | Faraday Laboratories, Inc. | Process for treating wet fat biological tissue using a water miscible solvent |
US4767746A (en) * | 1985-12-04 | 1988-08-30 | Trustees Of Boston University | Method for enhancement of healing of epithelial wounds in mammals |
GB8618374D0 (en) * | 1986-07-28 | 1986-09-03 | Hsc Res Dev Corp | Biological vascular prostheses |
US5336616A (en) * | 1990-09-12 | 1994-08-09 | Lifecell Corporation | Method for processing and preserving collagen-based tissues for transplantation |
US6152142A (en) * | 1997-02-28 | 2000-11-28 | Tseng; Scheffer C. G. | Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries |
US8563232B2 (en) * | 2000-09-12 | 2013-10-22 | Lifenet Health | Process for devitalizing soft-tissue engineered medical implants, and devitalized soft-tissue medical implants produced |
US6734018B2 (en) * | 1999-06-07 | 2004-05-11 | Lifenet | Process for decellularizing soft-tissue engineered medical implants, and decellularized soft-tissue medical implants produced |
EP1278559B1 (de) * | 2000-04-28 | 2008-03-26 | Baylor College Of Medicine | Dezellularisierte gefässprothesen |
DE10064948C1 (de) * | 2000-12-20 | 2002-07-11 | Auto Tissue Gmbh | Verfahren zur Dezellularisierung von Fremdmaterial zur Herstellung von Bioprothesen und Vorrichtung zur Durchführung des Verfahrens |
CN1218755C (zh) * | 2001-07-27 | 2005-09-14 | 北京科宇联合干细胞生物技术有限公司 | 一种干细胞再生表层角膜及其作为角膜移植材料的用途 |
JP2005504032A (ja) * | 2001-07-31 | 2005-02-10 | ファイザー・プロダクツ・インク | エストロゲン・アゴニスト/アンタゴニスト、エストロゲン及びプロゲスチンの組み合わせを含む医薬組成物、キット及び方法 |
US20030187515A1 (en) * | 2002-03-26 | 2003-10-02 | Hariri Robert J. | Collagen biofabric and methods of preparing and using the collagen biofabric |
EP1641915B1 (de) * | 2003-06-27 | 2016-07-27 | DePuy Synthes Products, Inc. | Reparatur und regenerierung von augengewebe mit postpartum abgeleiteten zellen |
US20050013870A1 (en) * | 2003-07-17 | 2005-01-20 | Toby Freyman | Decellularized extracellular matrix of conditioned body tissues and uses thereof |
WO2005089823A1 (ja) * | 2004-03-19 | 2005-09-29 | Japan Science And Technology Agency | 再生管腔臓器着生剤、着生可能型再生管腔臓器、着生可能型再生管腔臓器の製造方法、及び管腔臓器の再生着生方法 |
JP2005345196A (ja) * | 2004-06-01 | 2005-12-15 | Yamada Yoshihiko | 超音波を使った脂肪組織の迅速処理法 |
WO2006036984A2 (en) * | 2004-09-28 | 2006-04-06 | Atrium Medical Corporation | Stand-alone film and methods for making the same |
US20060171930A1 (en) * | 2004-12-21 | 2006-08-03 | Agnieszka Seyda | Postpartum cells derived from umbilical cord tissue, and methods of making, culturing, and using the same |
CN1903143A (zh) * | 2005-07-29 | 2007-01-31 | 广东冠昊生物科技有限公司 | 生物型人工血管及其制备方法 |
-
2007
- 2007-12-19 US US11/960,010 patent/US20090163990A1/en not_active Abandoned
-
2008
- 2008-12-04 CA CA2709998A patent/CA2709998A1/en not_active Abandoned
- 2008-12-04 AU AU2008343485A patent/AU2008343485B2/en not_active Ceased
- 2008-12-04 WO PCT/US2008/085450 patent/WO2009085547A2/en active Application Filing
- 2008-12-04 BR BRPI0821406-9A patent/BRPI0821406A2/pt not_active IP Right Cessation
- 2008-12-04 EP EP08867075A patent/EP2229191B1/de not_active Not-in-force
- 2008-12-04 AT AT08867075T patent/ATE542553T1/de active
- 2008-12-04 CN CN200880127136.1A patent/CN101945676B/zh not_active Expired - Fee Related
- 2008-12-04 JP JP2010539598A patent/JP5599722B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN101945676B (zh) | 2014-07-09 |
EP2229191A2 (de) | 2010-09-22 |
CN101945676A (zh) | 2011-01-12 |
WO2009085547A2 (en) | 2009-07-09 |
BRPI0821406A2 (pt) | 2015-06-16 |
JP2011507608A (ja) | 2011-03-10 |
AU2008343485A1 (en) | 2009-07-09 |
EP2229191B1 (de) | 2012-01-25 |
AU2008343485B2 (en) | 2013-08-22 |
WO2009085547A3 (en) | 2010-04-15 |
JP5599722B2 (ja) | 2014-10-01 |
CA2709998A1 (en) | 2009-07-09 |
US20090163990A1 (en) | 2009-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE542553T1 (de) | Dezellularisierte omentummatrix und ihre verwendung | |
IL273422A (en) | Methods and systems for extracorporeal organ treatment | |
UY31984A (es) | DERIVADOS DE 1-(3,4-difluorobencil)-6-oxo-1,6-dihidropirimidin-5-carboxamidas N-sustituidas y de 2-(3,4-difluorobencil)-3-oxo-2,3-dihidro-1H-pirazol-4-carboxamidas N-sustituidas. | |
EP2588592A4 (de) | Verwendung von perfusions-dezellularisierten organen für abgeglichene rezellularisierung | |
MY159971A (en) | Multipotent/pluripotent cells and methods | |
MX2009006071A (es) | 4-fenil-pirano-3,5-dionas,4-fenil-tiopirano-3,5-dionas y ciclohexanotrionas como herbicidas novedosos. | |
WO2008091835A3 (en) | Implantable medical endoprostheses | |
ATE502063T1 (de) | Wasserdispergierbare, hochfunktionelle polyisocyanate | |
SG10201906304TA (en) | Use of perfusion decellularized liver for islet cell recellularization | |
NO20083940L (no) | Fremgangsmater for redusering av proteinaggregering | |
MX2009004883A (es) | Piridil sulfoximinas multi-substituidas y su uso como insecticidas. | |
CL2009000393A1 (es) | Composición farmaceutica que comprende a) un agente farmaceutico activable, b) un agente activo plasmonico; util para el tratamiento de trastornos de proliferación celular. | |
NI201000044A (es) | Bromhidrato de bupropión y aplicaciones terapéuticas | |
MX354904B (es) | Uso combinado de proteínas cry1ca y cry1fa para el manejo de la resistencia de insectos. | |
WO2007103666A3 (en) | Implantable medical endoprosthesis delivery systems | |
MX338336B (es) | Polipeptidos de insulina modificados y sus usos. | |
HK1136847A1 (en) | Targeted integration into the ppp1r12c locus | |
MX2009008430A (es) | Anticuerpos anti-robo4 y sus usos. | |
UA103774C2 (uk) | Модифіковані поліпептиди бичачого гранулоцитарного колонієстимулювального фактора (g-csf) та їх застосування | |
CO6351786A2 (es) | Inkibidores de la cinasa map p38 | |
EA200802111A1 (ru) | Имплантаты для лечения состояний, ассоциируемых с допамином | |
CL2008001682A1 (es) | Metodos para el mejoramiento de plantas mediante el uso de informacion directa de secuencias de acidos nucleicos. | |
TW200715634A (en) | Stable organic devices | |
ATE547130T1 (de) | Biokompatibles implantat | |
UY32659A (es) | Pirazinilpirazoles |